Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope and definitions
1.3 Base estimates and working
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Connected drug delivery devices market industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Device type trends
2.1.3 Technology trends
2.1.4 Application trends
2.1.5 End-use trends
2.1.6 Regional trends
Chapter 3 Connected Drug Delivery Devices Market Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising patient awareness about adherence to prescribed therapies
3.3.1.2 Rapidly moving healthcare IT infrastructure
3.3.1.3 Soaring adoption of machine learning, and artificial intelligence (AI)
3.3.1.4 Rising implementation of telehealth platform integrated with AR/VR technologies
3.3.2 Industry pitfalls & challenges
3.3.2.1 Security concerns regarding patient data
3.3.2.2 High price of the device
3.4 Growth potential analysis
3.4.1 By device type
3.4.2 By technology
3.4.3 By application
3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S,
3.6.2 Europe
3.6.3 Asia
3.6.3.1 China
3.6.3.2 Japan
3.6.3.3 India
3.7 Technology landscape
3.8 Reimbursement scenario
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
4.7 Strategy dashboard
Chapter 5 Connected Drug Delivery Devices Market, By Device Type
5.1 Key device type trends
5.2 Connected sensors
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Connected inhalation sensors
5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3 Connected injectable sensors
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Integrated devices
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Integrated inhalation devices
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 Integrated injectable devices
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Connected Drug Delivery Devices Market, By Technology
6.1 Key technology trends
6.2 Bluetooth
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Near Field Communication
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Wi-Fi
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Connected Drug Delivery Devices Market, By Application
7.1 Key application trends
7.2 Anaphylaxis
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Respiratory
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Cardiovascular
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Diabetes
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.6 Hormone replacement
7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.7 Others
7.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Connected Drug Delivery Devices Market, By End-use
8.1 Key end-use trends
8.2 Hospital
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Clinics
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Homecare settings
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Others
8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Connected Drug Delivery Devices Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Poland
9.3.7 Switzerland
9.3.8 Netherlands
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Thailand
9.4.7 Indonesia
9.4.8 Vietnam
9.5 Latin America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Columbia
9.5.4 Mexico
9.5.5 Peru
9.6 MEA
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 Israel
9.6.4 UAE
Chapter 10 Company Profiles
10.1 Adherium
10.2 Bayer AG
10.3 BioCorp Production
10.4 Findair Sp. z o. o.
10.5 Merck
10.6 Nemera
10.7 Phillips Medisize
10.8 Propeller Health
10.9 Teva Pharmaceuticals
10.10 West Pharmaceutical Services
